Concepedia
Statistics
Publications
8
Citations
471
H-Index
Active since
2003
Affiliations
Bayer (Germany)(Current)
Retriev Technologies (United States)
Lux Research (United States)
Charles River Laboratories (United States)
BASF (Germany)
Werner Bomann is an author at Bayer (Germany) specializing in carcinogenesis, mechanisms of carcinogenicity, and pharmacology.
Publications per year
2003–2021
Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver
Heidrun Ellinger‐Ziegelbauer, Barry P. Stuart, B. Wahle et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2005 · 213 citations
Pharmacy, Genetics, Toxicology +15
Characteristic Expression Profiles Induced by Genotoxic Carcinogens in Rat Liver
Heidrun Ellinger‐Ziegelbauer, Barry P. Stuart, B. Wahle et al. · Toxicological Sciences · 2003 · 161 citations
Pharmacy, Molecular Genetics, Toxicology +17
Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors
Richard C. Peffer, Matthew J. LeBaron, Michael Battalora et al. · Regulatory Toxicology and Pharmacology · 2018 · 22 citations · Full text
Medicine, Oncology, Pharmacology +17
Relationship of Metabolism and Cell Proliferation to the Mode of Action of Fluensulfone-Induced Mouse Lung Tumors. II: Additional Mechanistic Studies
Christian Strupp, Werner Bomann, Samuel M. Cohen et al. · Toxicological Sciences · 2016 · 19 citations
Medicine, Cancer Biology, Toxicology +17
Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): Liver carcinogenesis
Christian Strupp, Nicolas Quesnot, Lysiane Richert et al. · Regulatory Toxicology and Pharmacology · 2020 · 17 citations
Medicine, Pharmacology, Toxicology +14
1–5 of 8